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Zyxin is an evolutionarily conserved protein that is concentrated a t sites of cell adhesion, where it associates 
with members of the Enabled (Ena)/vasodilator-stim ulated phosphoprotein (VASP) family of cytoskeletal 
regulators and is postulated to play a role in cytoskeletal dynamics and signaling. Zyxin transcripts are 
detected throughout m urine embryonic development, and the protein is widely expressed in adults. Here we 
used a reverse genetic approach to examine the consequences of loss of zyxin function in the mouse. Mice that 
lack zyxin function are viable and fertile and display no obvious histological abnormalities in any of the organs 
examined. Because zyxin contributes to the localization of Ena/VASP family members at certain subcellular 
locations, we carefully examined the zyxin_/_ mice for evidence of defects that have been observed when 
Ena/VASP proteins are compromised in the mouse. Specifically, we evaluated blood platelet function, nervous 
system development, and skin architecture but did not detect any defects in these systems. Zyxin is the 
founding member of a family of proteins tha t also includes the lipoma preferred partner (LPP) and thyroid 
receptor-interacting protein 6 (TRIP6). These zyxin family members display patterns of expression that 
significantly overlap tha t of zyxin. W estern blot analysis indicates that there is no detectable upregulation of 
either LPP or TRIP6 expression in tissues derived from zyxin-null mice. Because zyxin family members may 
have overlapping functions, a comprehensive understanding of the role of these proteins in the mouse will 
require the generation of compound mutations in which multiple zyxin family members are simultaneously 
compromised.
Zyxin is a LIM domain protein that is present at sites of 
cell-substratum and cell-cell adhesion, where it is proposed to 
dock proteins involved in cytoskeletal organization and dynam­
ics (7, 8, 11, 16). Biochemical studies have identified a-actinin, 
members of the Enabled (Ena)/vasodilator-stimulated phos­
phoprotein (VASP) family, Vav, members of the cysteine-rich 
protein family, the LATS I tumor suppressor, and members of 
the p!30cas family as binding partners for zyxin (12, 19, 23, 24, 
42, 43, 47, 56). The molecular architecture of zyxin is compat­
ible with the protein’s postulated role as a scaffold for the 
assembly of multimeric protein complexes. Zyxin displays 
three tandemly arrayed LIM domains, double zinc finger struc­
tures that support specific protein interactions (37, 47). In 
addition, zyxin exhibits at least one nuclear export signal that 
regulates its excursions between the nucleus and the cytoplasm 
(35, 36).
Zyxin also displays four proline-rich ActA repeats that can 
interact directly with members of the Ena/VASP family ( 14, 19, 
34). Members of the Ena/VASP family are concentrated at 
focal adhesions, the leading edge of lamellipodia, and filopo-
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dial tips (19, 42). Ena/VASP proteins are involved in modula­
tion of actin assembly and organization (4, 6, 30, 41, 48) and 
are required for normal fibroblast and neuron migration (5, 
20). Recent work has illustrated that the proper subcellular 
targeting of Ena/VASP family members is essential for them to 
fulfill their normal roles in vivo (I, 5, 6).
The Ena/VASP binding capacity of zyxin has been studied in 
detail, and several lines of evidence suggest that zyxin plays an 
important role in localizing members of this family to sites of 
cell-substratum adhesion. For example, microinjection of pep­
tides that cause displacement of zyxin from focal adhesions 
also results in loss of Ena/VASP family members from these 
sites (15). In complementary experiments, targeting of zyxin to 
membranes or mitochondria leads to recruitment of Ena/ 
VASP proteins (14, 18). Moreover, microinjection of peptide 
inhibitors that interfere with the binding of Ena/VASP pro­
teins to partners with ActA repeats, such as zyxin, disturbs the 
subcellular distribution of Ena/VASP proteins and affects cell 
spreading and cell-cell adhesion (14, 52). Collectively, these 
studies suggest that failure of Ena/VASP proteins to localize 
properly results in defects in actin-based cell functions and 
implicate zyxin as an important contributor to the proper lo­
calization of Ena/VASP proteins.
The physiological consequences of disturbing Ena/VASP 
function have been characterized in vertebrates by analysis of 
mice in which Mena (mammalian Ena) or VASP functions 
have been compromised by gene disruption or expression of
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FIG. 1. Zyxin structure and expression. (A) Zyxin architectural fea­
tures including the a-actinin binding site, four proline-rich ActA re­
peats for binding to M ena and VASP, the leucine-rich nuclear export 
sequence (NES), and three double zinc finger I.IM domains. Epitopes 
recognized by several antizyxin antibodies used in our analysis are 
marked with arrowheads; mouse monoclonal antibodies (1D1, 164D4, 
and 12A12) are above the rabbit polyclonal antibodies (B38, B72, and 
B71). (B) Northern blot of 2 jxg of polyadenylated RNA isolated from 
mouse embryos (day 7, day 11, day 15, and day 17 of gestation) reveals 
that zyxin transcripts are present throughout embryogenesis. 
(C) Northern blot of 2 jxg of polyadenylated RNA isolated from adult 
mouse tissues illustrates widespread expression of zyxin transcripts in 
the adult mouse. The Northern blots shown were probed with a zyxin 
cDNA that encodes the C-terminal LIM domains. To ensure that no 
transcripts encoding irrelevant LIM proteins were contributing to the 
signal, the blots were stripped and reprobed with a zyx/'/i-specific 3' 
untranslated region probe; identical signals were obtained (data not 
shown). As an additional control, the blots were stripped and reprobed 
to detect glyceraldehyde-3-phosphate dehydrogenase (GAPDH) tran­
scripts, which are present at variable levels depending on the tissue type.
m utant constructs. Although micc that lack either Mena or 
VASP are viable and fertile, compromising the functions of 
murine Ena/VASP family members results in disturbed plate­
let function, nervous system development, and epithelial sheet 
formation (3, 21, 29, 52). Here we pursued a reverse genetic 
strategy to probe the role of zyxin in the mouse. We generated 
mice that lack zyxin function and analyzed the importance of 
zyxin for embryonic development and adult functions, with 
particular attention to processes that are known to depend on 
members of the Ena/VASP family. Mice that lack zyxin are 
both viable and fertile and do not display defects in processes 
that are compromised when either VASP or Mena functions 
are eliminated. The existence of multiple zyxin family members 
may obscure our ability to detect the contribution of zyxin to 
these processes.
MATERIALS AND METHODS
Northern blot analysis, zyxin transcript levels were analyzed by probing mouse 
embryo and adult multiple tissue Northern blots containing 2 fig of polyadenyl­
ated RNA per lane (Clontech Laboratories, Palo Alto, Calif.). Both a zyxin LIM 
domain DNA probe and & zyxin 3' untranslated region DNA were labeled by nick 
translation with [33P]dCTP and used to probe the Northern blots by standard 
methods (2). Glyceraldehyde-3-phosphate dehydrogenase transcript levels were 
monitored as a control.
zxyin targeting construct and generation of zyxin-mill mice. All mice were 
maintained in a specific-pathogen-free barrier facility and cared for, handled, 
and euthanized following guidelines approved by the Institutional Animal Care 
and Use Committee of the University of Utah. The neomycin resistance selection 
cassette pKT31ox(A) and the pTKl-pTK2-C targeting vector were provided by 
Kirk Thomas (University of Utah Transgenic Core Facility). The 19-kb mouse 
genomic DNA construct was isolated by screening a LambdaFix mouse 129 
phage library with a murine zyxin cDNA probe (31).
To generate the targeting construct, a 4.5-kb genomic region that encompasses 
the translation initiation codon was replaced with a neomycin resistance cassette 
(neo) for positive selection. Deletion of the 4.5-kb DNA would remove a 5' 
noncoding exon and the first four coding exons for zyxin. Two thymidine kinase- 
negative selection cassettes flanked the targeting construct. To assist in cloning 
and screening, the Spel site was deleted from the 5' end of the neomycin 
resistance coding sequence, and a new Spel site was added to the 3' end of the 
neomycin resistance cassette in the targeting construct. The linearized .zyxin gene 
targeting construct was electroporated into the 129SVJ GS stem cell line (Ge­
nome Systems Inc., St. Louis, Mo.), and recombinant clones were selected.
Positive embryonic stem (ES) cell lines were screened for correct homologous 
recombination by Southern DNA analysis. Cells from two independently derived 
ES cell lines (86 and 185) were introduced separately into recipient morulae to 
generate chimeric mice. The resulting chimeric mice were mated with C57BL/6 
mice (Jackson Laboratory, Bar Harbor, Maine). Tail DNAs from agouti mice in 
the resulting litters were analyzed by Southern blot to identify mice in which the 
targeted allele was transmitted via the germ line. These heterozygous mice 
served as the founders for two independent zyxin^H  mouse lines (Zyxin-86 and 
Zyxin-185). The mouse genome database provided information on the intron- 
exon boundaries and locations within the zyxin gene and the chromosome loca­
tions for zyxin gene family members (ncbi.nlm.nih.gov/genome/guide/mouse).
Characterization of ES cell lines and mice. Genomic DNA was prepared from 
mouse tails by 55°C incubation with 10 mg of proteinase K per ml in 0.5% sodium 
dodecyl sulfate (SDS), 50 mM Tris (pH 8), and 100 mM EDTA (25). For 
Southern DNA analysis, the DNA was digested with Spel and then electropho- 
resed through a 0.8% agarose gel, depurinated (0.25 M IIC! for 10 min), followed 
by capillary transfer (0.4 M NaOH) to nylon filters for 18 h. The DNA was 
neutralized (20 min in 0.5 M Tris-HCl [pH 7.5], 1.5 M NaCl), washed in 2x SSPE 
(20 min), dried, and UV cross-linked. The 3' EcoRl-Hindlll DNA fragment was 
labeled with [33P]dCTP (Ready To Go DNA labeling beads; Amersham Phar­
macia, Piscataway, N.J.), and used to probe the DNA filters (1 h at 65°C). After 
washing at 42°C (0.1% SDS with sequential steps of 2X SSPE, l x  SSPE, and 
0.1 x  SSPE), the blot was developed by autoradiography (wild-type zyxin, 11.8 
kb; null mutant, 6.2 kb).
For PCR analysis, the genomic DNA was incubated with three primers, 
WTFzyx (5'-TAC AAG GGC GAA GTC AGG GCG AGT G-3'), WTRzyx 
(5'-TGG ACG AAG TTT CCG TGT GTT G-3'), and NEOFzyx (5'-GAC CGC 
TTC CTC GTG CTT TAC-3') and a 30-cycle PCR regimen of 95°C for 60 s, 58°C 
for 30 s, and 72°C for 50 s, followed by 95°C for 1 min and 72°C for 3 min. The 
PCR products (wild-type zyxin, y i l  bp; null mutant, 473 bp) were electropho- 
resed on a 1.8% agarose gel and visualized with ethidium bromide.
For analysis of proteins, tissues were dissected from mice (euthanized by 
Halothane inhalation followed by cervical dislocation), weighed, homogenized in 
5 parts II20  with protease and phosphatase inhibitors (100 mM phenylmethyl- 
sulfonyl fluoride, 100 mM benzamidine HC1, 1 mg of pepstatin A per ml, 1 mg 
of phenanthroline per ml, 0.1 M NaF, 0.2 mM sodium orthovanadate), and 
diluted with an equal amount of Laemmli sample buffer (28). The tissue homog- 
enates were boiled for 5 min, and the DNA was sheared with a 26-gauge needle. 
Protein extracts (10 |xl) were electrophoresed through denaturing 10% polyacryl­
amide gels and either Coomassie stained or transferred to nitrocellulose by 
standard methods (51). Western immunoblot analysis was performed by en­
hanced chemiluminescence (Amersham Pharmacia, Piscataway, N.J.) for detec­
tion.
Antibodies. Polyclonal rabbit antizyxin serum B71 was generated by immuniz­
ing a rabbit with keyhole limpet hemocyanin coupled to peptide CSPGAPG 
PLTLKEVEELEQLT (human zyxin amino acids 344 to 363, encompassing the 
nuclear export sequence). Polyclonal rabbit antizyxin serum B72 was generated 
by immunizing a rabbit with keyhole limpet hemocyanin coupled to peptide 
CDFPLPPPPLAGDGDDAEGAL (human zyxin amino acids 70 to 89, encom­
passing the first ActA repeat). Rabbit immunizations and serum collection (se-
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FIG. 2. Disruption of murine zyxin gene. (A) Partial restriction map of the zyxin genomic region used for generation of the targeting construct. 
Restriction enzyme sites on the wild-type zyxin gene, the targeting vector, and the correctly targeted DNA following homologous recombination 
are shown. This approach deleted 4.5 kb of zyxin genomic sequence, which includes a 5' noncoding exon (small shaded box) and the first four coding 
exons (small white boxes) for amino acids 1 to 333. The ATG methionine start codon in the first coding exon and the TGA stop codon in the final 
coding exon are shown. (B) Southern blot of Apel-digested genomic DNA from two neomycin-resistant embryonic stem (ES) cell lines probed with 
the 3' 1.2-kb & oR I-ffindIII DNA identified correctly targeted DNA (wild type, 11.8 kb; targeted mutant, 6.2 kb). (C) Southern blot of 
Spel-digested genomic DNA from mouse tail samples distinguishes wild-type (H /H ), heterozygous (H / - ) ,  and homozygous-null ( - / - )  genotypes. 
(D) Genomic PCR with zyxin- and neo-specific primers with mouse tail genomic DNA confirms the wild-type (H /H ), heterozygous (H / - ) ,  and 
homozygous-null ( - / - )  genotypes (wild type, 327 bp; zy.wn-null, 473 bp). (E) W estern blot analysis of lung and spleen tissue extracts from zyxin 
wild-type ( H /H ), heterozygous ( H / - ) ,  and homozygous-null ( - / - )  mice with antizyxin antibody 164D4. No zyxin protein was detected in samples 
derived from the giv/n-null mouse with any of the antibodies specific for epitopes located throughout the zyxin protein.
rum samples B71 and B72) were performed al Harlan Bioproducts for Science 
(Madison, Wis.). Polyclonal rabbil serum B38 (31) is now known (o recognize 
both /yxin and lipoma preferred partner (I.PP) and is therefore referred lo as a 
pan/yxin antibody. Zyxin antisera were diluted 1:10,000 for Western blot analysis.
Mouse monoclonal antizyxin antibody 1D1 was generated by immunizing mice 
with bacterially expressed glutathione S-transferase (GST)-human zyxin; the 
epitope maps to WAPKPKVNPFRPGDSEPPP (human zyxin amino acids 28 to 
48). Mouse monoclonal antibody 12A12 recognizes T.TM3 of both zyxin and 
TRIP6. Mouse monoclonal antibody 164D4 against human zyxin was supplied by 
Matthias Krause and Jurgen Wehland (45). Polyclonal rabbit serum MP2 against 
I.PP was supplied by Marleen Petit and Wim Van de Ven (38). Polyclonal rabbit
serum B65 (supplied by Susanne Kloeker) is directed against mouse TRIP6 
peptide KQPEPSRT.PQGRST.PR and was affinity purified for these studies. 
Antibodies directed against laminin (Sigma-Aldrich, St. I.ouis, Mo.), keratin 1, 
keratin 5, loricrin (BabCo, Berkeley, Calif.), and fillagrin (BabCo, Berkeley, 
Calif.) were used as described previously (40).
Plalelels. Platelet-rich plasma was prepared from blood collected from wild- 
type and jyxm ' mice by established procedures (3). Platelets were exposed to 
collagen, and the timing of the resulting shape change and aggregation response 
was measured with a lumiaggregometer (Aggrecorder II PA-3220; Kyoto Kaiichi 
Kagaku, Kyoto, Japan) as described previously (3, 57). Both collagen and ADP 
were used as agonists.
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TABLE 1. Genotypes of progeny resulting from heterozygous 
(zyxin+/ ) intercrosses
Genotype No. of mice generated (% of total)
No. predicted by 
Mendelian genetics 
of total)
zyxin 72 (23) 78(25)
zyxin 162(52) 155 (50)
zyxin 77(25) 78 (25)
Platelet-rich plasma was prepared for Western blot analysis as follows. After 
anesthetization and cardiac puncture of three wild-type and three zyxm~f~ mice, 
blood was collected into 1.5-ml microcentrifuge tubes containing 20 jxl of anti­
coagulant citrate dextrose (110 mM sodium citrate [pH 7.4], 2.45% dextrose) 
plus 250 |xl of blood per tube. Phosphate-buffered saline containing 4.4 mM 
EDTA and 0.5% bovine serum albumin was added to the blood-anticoagulant 
citrate dextrose mixture (400 jxl per tube). Centrifugation at 1,000 rpm (Eppen- 
dorf microcentrifuge) for 10 min sedimented the red and white blood cells. The 
supernatant was recentrifuged at 2,700 rpm for 4 min and aspirated. Next, 300 |xl 
of ammonium chloride solution (150 mM ammonium chloride, 1 mM potassium 
bicarbonate, 0.1 mM EDTA, pH 7.4) was added to each pellet and mixed, 
followed by the addition of 400 jxl of phosphate-buffered saline-EDTA-bovine 
serum albumin and centrifugation at 2,700 rpm for 4 min. After the platelet 
pellets were washed twice in phosphate-buffered saline-EDTA-bovine serum 
albumin and evaluated by microscopic inspection, they were resuspended in SDS 
sample buffer, electrophoresed (approximately 400,000 platelets per lane), trans­
ferred, and probed as described above.
Histology and immunocytochemistry. For general histological analysis to com­
pare wild-type and zyxin mice, tissues were dissected, fixed, embedded, and 
stained as described previously (9). For examination of brain morphology, silver 
staining was performed on five adult brains sectioned along the horizontal plane 
to evaluate possible commissure defects (29). Immunocytochemical analysis of 
tail skin from newborn mice was performed as described previously (40, 52).
Flow cytometry. Blood samples (0.5 ml) from mice of various zyxin genotypes 
were incubated with labeled antibodies specific for mouse blood cell markers. 
The labeled blood cells were then sorted into populations of B cells, T cells 
(CD4+ and CD8 + ), granulocytes, and monocytes by flow cytometry (University 
of Utah Flow Cytometry Core Facility). The blood cell populations were ana­
lyzed for standard error means and paired t tests with Prism software (Graph 
Pad, San Diego, Calif.).
RESULTS
Knowledge of zyxin’s binding partner repertoire as well as its 
molecular architecture suggests that the protein serves as a 
scaffold for the docking of multiple protein partners (Fig. 1A) 
(12, 19, 23, 24, 42, 43, 46, 47, 56). One of zyxin’s notable 
features is the presence of four proline-rich motifs called ActA 
repeats. These repeats were first identified in the ActA protein 
of Listeria monocytogenes, where they make a contribution to 
the intracellular motility of this pathogenic bacterium (30, 34). 
ActA repeats serve as docking sites for members of the Ena/ 
VASP family (34, 44). Ena/VASP proteins contribute to the 
control of actin assembly and organization (4, 44) and have
been shown to play important roles in platelets, neurons, and 
keratinocytes in the mouse (3, 29, 42, 52). Because zyxin plays 
a central role in localizing Ena/VASP proteins to certain sub- 
cellular locations (15), we postulated that elimination of zyxin 
function may perturb processes that depend on Ena/VASP 
proteins.
In order to test this hypothesis and to learn more about the 
physiological role of zyxin in vivo, we examined zyxin function 
in a mouse model system. By Northern analysis, we determined 
that murine zyxin is encoded by a single transcript of 2.4 kb 
that is expressed throughout embryonic development (Fig. 
IB). Evaluation of zyxin RNA expression in adult mouse tis­
sues indicated that zyxin is ubiquitously expressed (Fig. 1C).
Targeted disruption of zyxin gene. In order to study the role 
of zyxin in the mouse, we generated a deletion allele by stan­
dard methods for engineering gene disruptions by homologous 
recombination (Fig. 2A) (10, 32). To abolish zyxin function, 
approximately 4.5 kb of zyxin gene sequence, including coding 
sequence for the translational initiation codon, was replaced 
with a neomycin resistance selection cassette. Inspection of the 
available mouse genome sequence confirmed that a 5' noncod­
ing exon plus four exons encoding amino acids 1 to 333 would 
be deleted by this strategy. Properly targeted ES cells were 
identified by Southern blot analysis (Fig. 2B) and were incor­
porated into recipient morulae. The resulting chimeric animals 
were bred to C57BL/6 mice to generate heterozygous mice, 
which were subsequently interbred. The progeny of zyxin w_ 
intercrosses were genotyped by either Southern blot (Fig. 2C) 
or PCR (Fig. 2D) analysis.
To evaluate the consequences of loss of zyxin function, 
zyxin w_ mice were intercrossed. The resulting progeny dis­
played a normal Mendelian ratio of zyxin w *\ zyxin w_, and 
zyxin- ''- animals (Table 1), indicating that zyxin is not abso­
lutely essential for development. To demonstrate that zyxin 
protein is indeed missing from the m w -nu ll mice, tissue ex­
tracts from wild-type, heterozygous, and m w -nu ll mice were 
analyzed by W estern blot. Analysis of two tissues, lung and 
spleen, that displayed relatively high levels of zyxin mRNA is 
shown in Fig. 2E. Tissues isolated from zyxin K'-  mice displayed 
reduced zyxin levels, and no zyxin was detected in tissues from 
zyxin- '-  animals. The absence of zyxin protein expression was 
confirmed with multiple antizyxin antibodies whose epitopes 
mapped to the N-terminal, central, and C-terminal regions of 
the protein (Fig. 1A and data not shown). Since the mouse 
genome sequence suggests that our targeting strategy would 
leave five coding exons for the C-terminal half of zyxin, it is 
important that our W estern blot analysis confirmed that there 
is no detectable expression of these partial zyxin products.
TABLE 2. Flow cytometry analysis of blood cell populations from wild-type (zyxin ' 1' ) heterozygous ( z y x i n ) and homozygous-null
(zyxin ' ) 1 it term ates‘7
Genotype
Mean % of total ± SEM
B cells T cells (CD44)
T cells 
(CDS4") Granulocytes Macrophages
Wild type 43.4 ±  4.8 26.9 ±  3.2 14.3 ±  1.1 15.5 ±  2.0 7.1 ±  1.5
Heterozygous 49.2 ±  4.8 24.2 ±  1.3 18.1 ±  2.9 20.8 ±  2.7 7.4 ±  0.9
Null 36.7 ±  4.3 29.5 ±  4.0 15.8 ±  1.2 14.0 ±  1.8 5.5 ±  0.6
a pour mjce per genotype were tested. The standard error of the mean was calculated with the Graph Pad Prism statistical analysis software.
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FIG. 3. Zyxin family member structure and protein expression. 
(A) Alignment of human zyxin family members. Certain sequence 
motifs present in zyxin, including an n-actinin binding site (diagonal 
bars), proline-rich ActA repeats (shaded), nuclear export sequence 
(NES) (horizontal bars), and three C-terminal LIM domains (solid), 
are also observed in zyxin’s closest relative, LPP. Another zyxin family 
member, TRIP6, displays a nuclear export signal and three C-terminal 
LIM domains. Accession numbers are X94991 (human zyxin) (31), 
NM_005578 (human LPP) (39), and AJ001902 (human TRIP6) (55). 
The mouse genome sequence database identifies the zyxin gene on 
mouse chromosome 6, the I^PP gene on mouse chromosome 16, and 
the TRIP6  gene on mouse chromosome 5. (B and C). Expression of 
zyxin family members in mice. In panel B, a Coomassie blue-stained 
gel of total lung protein from zyxin ' ' ' ,  zyxin ' '  \  and zyxin mice is 
shown to illustrate comparable protein loading. As can be seen in the 
W estern immunoblots shown in panel C, zyxin (B71 antiserum), LPP 
(MP2 antiserum), and TRIP6 (affinity-purified B65 antibody) are all 
expressed in wild-type lung tissue. Zyxin protein is reduced in samples 
from zyxin* '"  animals and is absent in zyxin animals. LPP and 
TRIP6 levels are unaffected when zyxin expression is eliminated.
zyxm animals can mate and produce offspring, indicat­
ing that zyxin expression is not essential for either male or 
female fertility. Histological examination of the tissues evalu­
ated by Northern analysis in Fig. IC revealed that theziaw-null 
mice displayed no obvious abnormalities in tissue architecture 
(data not shown). Since zyxin is highly expressed in blood cells 
(31), we examined the white blood cell population of four sets 
of littermates with assorted zyxin genotypes (+ /+ , + /—, and 
—/ —). Flow cytometric analysis indicated that loss of zyxin did 
not significantly affect resting populations of B cells, T cells 
(CD4+ or CD8+), granulocytes, or monocytes (Table 2).
Expression of zyxin family members is not upregulated in 
zyxin~'~ animals. Recently, two proteins that show a high 
degree of structural similarity to zyxin have been identified 
(Fig. 3A). LPP is the closest zyxin relative, with conserved 
proline-rich ActA repeats, LIM domains, and almost identical
mobility in SDS-PAGE (38). Zyxin and LPP exhibit overlap­
ping tissue expression and a similar subcellular distribution, 
and they also share some binding partners (31, 38, 39). Thyroid 
receptor-interacting protein 6 (TRIP6), also called zyxin-re- 
lated protein (ZR P-I), has significant amino acid identity with 
human zyxin, particularly in the three C-terminal LIM domains 
(33, 53, 55). Zyxin, LPP, and TRIP6 have all been shown to 
localize at sites of cell adhesion ( 11, 38, 53). The shared archi­
tectural features and subcellular localizations of these proteins 
suggest that they may have common functions in vivo.
We examined whether the expression of either LPP or 
TRIP6 is elevated in the zyxin-nu\\ mice because upregulation 
of these proteins could theoretically compensate for elimina­
tion of zyxin expression. Total protein isolated from the lung, 
spleen, bladder, kidney, heart, and liver samples derived from 
zyxin+,+, zyxin+'~ , and zyxin~'~ animals were probed with an­
tibodies that specifically recognize zyxin, LPP, and TRIP6. 
Western blot analysis of lung, a tissue that expresses particu­
larly high levels of zyxin (Fig. IC), is shown in Fig. 3B and C. 
Zyxin levels were reduced by approximately one half in the 
heterozygote, and, as expected, no zyxin protein was observed 
in the sample derived from the zyxin~'~ lung. No change in 
either LPP or TRIP6 protein levels was detected when zyxin 
function was compromised by mutation (Fig. 3C). Results sim­
ilar to these shown with lung tissue were also found for blad­
der, spleen, kidney, heart, and liver (data not shown). These 
results illustrate that upregulated expression of zyxin family 
members does not occur in response to mutation of the zyxin 
gene. Interestingly, we found that all of the wild-type tissues 
examined displayed expression of at least two zyxin family 
members (data not shown). Therefore, although no compen­
satory upregulated expression of zyxin family members was 
observed, it remains possible that the presence of multiple 
family members contributes to the survival of the mice.
As discussed above, one of the best-characterized biochem­
ical activities of zyxin is its ability to bind members of the 
Ena/VASP family and contribute to the proper subcellular 
localization of these proteins to sites of cell adhesion. Like 
zyxin-nu\\ animals, mice that lack either VASP or Mena are 
viable and fertile. However, higher-resolution analysis revealed 
contributions of Ena/VASP proteins to platelet function (21), 
axon guidance (29), and epithelial sheet formation (52). There­
fore, we examined the consequences of eliminating zyxin func­
tion for these three systems in which zyxin is postulated to 
contribute via its capacity to dock Ena/VASP proteins.
Analysis of zyxin-deficient platelet function. Two groups 
have generated mice that lack VASP function (3, 21). These 
mice are viable and fertile but display an altered platelet acti­
vation response. Resting platelets are discoid, nonadhesive 
cells. When exposed to an agonist such as collagen, thrombin, 
or ADP, they become activated; they rapidly change their 
shape and begin to aggregate with each other. The precise 
timing and extent of these two responses to agonist can be 
monitored by the use of an aggregometer, which detects these 
two stages as changes in light transmission (57). Although the 
patterns of expression of Mena and VASP often overlap, plate­
lets provide an example of a cell that expresses primarily VASP 
(3), enhancing the likelihood of being able to detect a VASP 
loss-of-function phenotype. Indeed, as can be seen in Fig. 4A, 
platelets that lacked VASP function underwent shape change
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FIG. 4. Platelet activation response is not altered by elimination of zyxin function. Platelets isolated from wild-type. V ASP  •' , and zyxin •' 
animals were stimulated with collagen (arrow) in the presence of calcium, and the platelet activation and aggregation responses were monitored 
by measuring light transmission. (A) As has been reported previously (3). V ASP  •' platelets display a precocious shape change response (#) but 
then proceed to aggregate to the same extent as wild-type platelets. (B) In contrast, the timing of the platelet shape change of zyxin ! platelets 
is similar to what is observed for wild-type platelets. The slight leftward shift of the aggregation trace shown for the zyxin •' platelets relative to 
wild-type platelets was not a consistent finding. (C) Expression of zyxin family members in platelets. Approximately 10 |xg of wild-type mouse 
embryo fibroblast (M EF) protein and comparable amounts of protein from wild-type platelets (P + /+ )  and zww-null platelets (P —/ —) were 
electrophoresed through SDS-lOCi polyacrylamide gels, transferred to nitrocellulose, and probed for zyxin family member expression. Zyxin 
protein (B71 antiserum) is detectable in mouse embryo fibroblasts and wild-type platelets but not in g;«'/)-null platelets. LPP (MP2 antiserum) is 
detectable in mouse embryo fibroblasts but is not detectable under these conditions in wild-type or m w -n u ll platelets. TRIP6 (affinity-purified B65 
antibody) is detectable in mouse embryo fibroblasts and is seen at low levels in both wild-type and zy.wz-null platelets. A  faint immunoreactive band 
that migrates at 66 kDa is detected with antizyxin (B71) antibody in both zyxin 1' '1 and zyxin ! platelets. This band was not observed in any other 
murine tissue that we analyzed and may reflect a platelet-expressed protein that has some similarity to zyxin. As expected for platelets, these 
platelet extracts were positive for VASP expression and negative for Mena expression by W estern blot analysis (data not shown).
precociously but ultimately aggregated to the same extent as 
their wild-tvpe counterparts (3). In contrast, the activation 
profiles of wild-tvpe and z y x i n platelets were completely 
coincident, and the platelets achieved comparable aggregation 
maxima (Fig. 4B), illustrating that zyxin is not required for 
normal platelet response.
To determine if multiple zyxin family members are ex­
pressed in platelets and to determine if their levels are altered 
in the absence of zyxin, a W estern blot analysis was performed 
(Fig. 4C). Zyxin was readily detected in wild-tvpe platelets but 
not in zyxin^'^ platelets. In equivalently loaded samples, small 
amounts of TRIP6 were observed but no LPP was detected. 
Thus, as in other tissues, multiple zyxin family members are 
expressed in platelets.
Analysis of nervous system development. Mice that lack 
Mena expression are also viable and fertile, but particular 
deficiencies in brain development were noted in approximately 
half of the mutant animals examined (29). Specifically, in 
M e m C brains, the corpus callosum and dorsal hippocampal 
commissure are absent, while the ventral hippocampal com­
missure is present but reduced in thickness. To evaluate these 
structures in zvm -null mice, we compared silver-stained sec­
tions of wild-tvpe, zyxin~'~, and Mena~'~  brains (Fig. 5). zvxin- 
null brains did not exhibit defects in any commissure in the 
brain (ventral or dorsal hippocampal commissures, anterior or 
posterior commissures, commissures of the superior and infe­
rior colliculi, habenular commissure, or decussation of the 
superior cerebellar peduncle). O ther major fiber tracts such as
wild type zyxin -/- Mena -/-
FIG. 5. Loss of zyxin function does not affect brain development. Horizontal sections from wild-type, zyxin •' , and M ena •' adult brains were 
analyzed by silver staining. The major commissures evident at this plane of section are the corpus callosum (cc) and the ventral hippocampal 
commissure (vhc). Brain structures, including those affected by loss of Mena function (29). such as the corpus callosum and ventral hippocampal 
commissure, form normally in the zyxin ! mice.
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the internal and external capsules also appeared to be unaf­
fected in 23*17/1 -null brains. Note that the ectopic callosal fibers 
seen contacting the ventral portion of the ventral hippocampal 
commissure in Mena- '-  brain (arrow) were not seen in the 
z y x i r r brain. Wc did not detect any deficits in axon guidance 
associated with elimination of zyxin function.
Analysis of epidermis. Transgenic mice expressing a frag­
ment of VASP thought to perturb function in their kcratino- 
cytes develop skin blisters that appear to result from pertur­
bation of cell-cell junctions (52). Expression of this mutant 
VASP disturbs the subcellular distribution of endogenous, full- 
length Ena/VASP family members (52). Because zyxin plays an 
important role in the proper subcellular localization of Ena/ 
VASP proteins, it was interesting to consider the possibility 
that elimination of zyxin might likewise lead to disturbances in 
the skin by compromising the normal subcellular localization 
of Ena/VASP family members.
The first step toward evaluating the possibility that zyxin 
plays a role in cellular adhesions in the skin was to examine the 
subcellular distribution of zyxin in the skin. As can be seen in 
Fig. 6A, zyxin was concentrated at the borders of wild-type 
epidermal keratinocytes. The basement membrane, which is 
demarcated by laminin, serves to separate the epidermis from 
the underlying dermis. The intensity of antizyxin labeling was 
more prominent at the cell borders of suprabasal layers, con­
sistent with the enhancement of intercellular junctions in these 
layers. As expected, the z^av/t-null mice showed no detectable 
zyxin protein anywhere in the epidermis (Fig. 6B). No visible 
abnormalities were noted in the skin or hair of the z^ '/i-null 
animals, and the skin of these mice also appeared normal at 
the histological level (Fig. 6C). The epidermis consisted of the 
standard morphologically distinct layers, and the hair follicles 
appeared normal.
To determine whether adhesion and VASP localization might 
be perturbed when zyxin is absent, wc assessed the status of 
E-cadherin and VASP in zyxin-nu\\ mouse skin. Interference 
with VASP function in transgenic mice caused blistering and 
loss of cell-cell contacts which manifested at the cellular level 
as double lines of E-cadherin between cells (52). In contrast, 
the zyxin-nu\\ mice exhibited normal E-cadherin and VASP 
localization (Fig. 6D and 6E, respectively).
To test whether the biochemical program of differentiation 
was normal in zyxin-nu\\ epidermis, wc used specific markers 
for the distinct layers of the stratified epithelium. The protein 
keratin 5, which is a marker for the basal layer of the epider­
mis, was unaltered in thcz3u7/i-null skin (Fig. 6F). Likewise, the 
spinous layers exhibited the normal differentiation program, as 
keratin 1 , an early marker of differentiation, was expressed 
immediately adjacent to the basal layer. Terminal differentia­
tion markers of epidermal differentiation such as loricrin (Fig.
6G) and filaggrin (Fig. 6H), which arc hallmarks of the gran­
ular layer, also showed normal expression patterns.
Altogether, these data suggest that both the adhesive and 
differentiation programs of the epidermis arc unaffected by the 
lack of zyxin. One possible explanation may be that the absence 
of phenotypic abnormalities is due to the presence of other 
zyxin family members which mask the consequences of loss of 
zyxin function. Indeed, wc determined that both an LPP-spc- 
cific antibody (38) and a panzyxin antibody that recognizes 
both zyxin and LPP (Fig. 61) labeled the cell borders of zyxin- 
null mouse skin, demonstrating the presence of LPP in the 
epidermal cell junctions.
DISCUSSION
Zyxin is an cvolutionarily conserved protein that has been 
implicated in cell adhesion, cell motility, and signaling. A num­
ber of zyxin binding partners have been identified by in vitro 
biochemical approaches. The roles of many of these partners 
have been elucidated by gene ablation studies in the mouse. 
For example, targeted disruption of the genes encoding 
p 13 0 Cas ancj Lats- | results in significant lethality (26, 49). Dis­
turbance of cither Mena or VASP function docs not lead to 
inviability but docs affect particular cell functions (3,21,29). In 
this study, wc generated mice in which the zyxin gene was 
disrupted. Here wc explored the possibility that elimination of 
the zyxin gene will have consequences similar to what occurs 
when Mena or VASP coding sequences arc ablated.
Among zyxin's binding partners, the interaction with Ena/ 
VASP family members is the best characterized. As discussed 
above, numerous studies have illustrated that zyxin serves as a 
docking site for Ena/VASP family members and is important 
for the proper subcellular targeting of these proteins to par­
ticular subcellular locations, most notably focal adhesions ( 1 , 
14, 15, 19, 34, 42). Therefore, it was anticipated that elimina­
tion of zyxin might disturb Ena/VASP function by ablating a 
key Ena/VASP docking site within cells. Based on that per­
spective, one might anticipate that elimination of zyxin would 
have similar consequences as elimination of Mena or VASP.
As was observed of individual targeted VASP and Mena gene 
disruptions in the mouse, mice that lack zyxin function arc 
viable and fertile. However, mutations in cither Mena or 
VASP or expression of a VASP deletion construct revealed 
deficiencies in platelet activation, neuronal pathfinding, and 
epithelial cell-cell adhesion (3, 21, 29, 52). Here wc examined 
the consequences of zyxin gene disruption for each of these 
processes. Despite the established contribution of zyxin to the 
docking of Mcna/VASP proteins at cell adhesion sites (14), 
V A S P and Mena- '-  phenotypes arc not recapitulated in 
the zyxin- '-  animals. Ena/VASP family members arc complex.
FIG. 6. Differentiation and architecture of the skin are normal in zyxin- '-  animals. Skins from wild-type (H /H ) (A) and qy.rm-null ( - / - )  (B 
to I) newborn mice were prepared for analysis. (A) Wild-type mouse skin stained for laminin (LAM) and zyxin (ZYX) exhibits normal basement 
membrane (BM) (laminin stain) and epidermal zyxin localization (B71 antizyxin polyclonal rabbit serum). (B) ry.rm-null mouse skin stained for 
laminin and zyxin. (C) qy.rm-null mouse skin stained with hematoxylin and eosin. BI., basal layer; SC, stratum corn cum; GR, granular layer; SP, 
spinous layer. (D to I) ry.rm-null mouse skin stained for E-cadhcrin and laminin (D), VASP and laminin (E), keratin 1 (K1) and keratin 5 (K5) 
(F), loricrin (LOR) and keratin 5 (G), filaggrin (FII.) and keratin 5 (H), and panzyxin (pan ZYX) (B38 antibody that detects both zyxin and LPP) 
and laminin (I), cpi, epidermis; de, dermis.
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multidomain proteins. One possible explanation for the obser­
vation that zyxin~'~ animals do not display the deficiencies 
observed in VASP~'~ and Mena~'~ mice is that phenotypes 
resulting from loss of Mena and VASP functions arc indepen­
dent of zyxin. For example, it is established that the localiza­
tion, and therefore presumably the function, of Ena/VASP 
family members at the distal tips of lamellipodial extensions 
and at sites of T-cell receptor clustering arc independent of 
zyxin (27, 45).
Alternatively, the consequences of losing zyxin could be 
masked by the expression of related proteins. Indeed, since 
initiating our efforts to target the zyxin gene, two proteins that 
arc closely related to zyxin, LPP and TRIP6, were identified 
(33, 38, 53, 55). We detected no upregulated expression of 
these proteins in the zyxin~'~ mice, so it docs not appear that 
the lack of dramatic phenotype can be attributed to compen­
satory changes in LPP or TRIP6 expression. However, zyxin 
family members display similar functional domains and subcel- 
lular distributions, and the three zyxin family members exhibit 
similar tissue distribution patterns (I I, 13, 31, 38, 39, 54, 55). 
Importantly, in the cases of blood platelets, brain, and skin, 
three tissues which we examined closely for a zyxin-nutt phe­
notype, we and others have detected expression of multiple 
zyxin family members (Fig. 4C and 61) (13, 31, 39).
This is the first report describing the ablation of a gene in the 
zyxin family. Although no basal phenotype has yet been ob­
served in the zyxin~'~ mice, consequences of eliminating the 
zyxin gene may emerge if these animals arc challenged by 
physiological stress. In order to assess further the role of the 
zyxin family in vivo, it will be of interest to disrupt the genes 
that encode other zyxin family members and to generate com­
pound mutations. There now exist many examples in which 
deletion of a single member of a gene family has minimal 
consequences but simultaneous elimination of multiple mem­
bers has a severe impact on development or adult physiology 
(17, 22, 50). The availability of a genetic model for studying 
zyxin function is a critical first step toward elucidating the role 
of zyxin.
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